Literature DB >> 7944930

Comparison of transjugular and surgical portosystemic shunts on the outcome of liver transplantation.

F Menegaux1, E B Keeffe, E Baker, H Egawa, W Concepcion, T R Russell, C O Esquivel.   

Abstract

OBJECTIVE: To analyze the effect of previous transjugular intrahepatic portosystemic shunt (TIPS) vs surgical portosystemic shunt (SPS) on the outcome of orthotopic liver transplantation (OLT).
DESIGN: A case series of 38 patients who underwent OLT: 25 with a previous TIPS and 13 with a previous SPS.
SETTING: A liver transplant center and interventional radiology service in a private, tertiary referral medical center. PATIENTS: Eighteen men and seven women who had a TIPS before OLT were compared with nine men and four women who had an SPS before OLT. MAIN OUTCOME MEASURES: Operative transfusion requirements, operative time, length of hospital stay, postoperative liver chemistry studies, and graft and patient survival.
RESULTS: Compared with patients who had an SPS, patients who had a TIPS had significantly less median transfusion requirements for packed red blood cells (5 vs 12 U), fresh-frozen plasma (0 vs 8 U), and thrombocytes (0 vs 1 U). The median operative time (9 vs 13 hours), length of intensive care unit stay (3 vs 5 days), and length of hospital stay (12 vs 24 days) were also significantly less in patients who had a TIPS. The 2-year actuarial patient survival rate was 92% in both groups.
CONCLUSIONS: In patients undergoing OLT, TIPS is associated with reduced operative transfusion requirements, operative time, and length of intensive care unit and hospital stays compared with SPS. In the potential liver transplant candidate with refractory complications of portal hypertension, TIPS is preferred to SPS.

Entities:  

Mesh:

Year:  1994        PMID: 7944930     DOI: 10.1001/archsurg.1994.01420340028006

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  5 in total

1.  Conversion of failed transjugular intrahepatic portosystemic shunt to distal splenorenal shunt in patients with Child A or B cirrhosis.

Authors:  N Selim; M J Fendley; T D Boyer; J R Galloway; G D Branum
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

Review 2.  Transjugular Intrahepatic Portosystemic Shunt before and after Liver Transplantation.

Authors:  Wael E Saad
Journal:  Semin Intervent Radiol       Date:  2014-09       Impact factor: 1.513

3.  A 27-year experience with surgical treatment of Budd-Chiari syndrome.

Authors:  M J Orloff; P O Daily; S L Orloff; B Girard; M S Orloff
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

4.  Effect of technical parameters on transjugular intrahepatic portosystemic shunts utilizing stent grafts.

Authors:  Brice Andring; Sanjeeva P Kalva; Patrick Sutphin; Rajiv Srinivasa; Alvin Anene; Marc Burrell; Yin Xi; Anil K Pillai
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

5.  Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis.

Authors:  Zai-Bo Jiang; Hong Shan; Xin-Ying Shen; Ming-Sheng Huang; Zheng-Ran Li; Kang-Shun Zhu; Shou-Hai Guan
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.